Literature DB >> 9145628

Factors associated with elective Norplant removal in black and white women.

J U Opara1, F A Ernst, H Gaskin, L Smith, H V Nevels.   

Abstract

Premature removal of contraceptive implants (Norplant [levonorgestrel implants], Wyeth-Ayerst Laboratories, Philadelphia, Pennsylvania) is a cause of a sizable national medical expenditure in the United States. Understanding the factors that influence the decision to remove the implants and being able to predict which users are likely to elect discontinuation prematurely could provide useful information for counseling patients as they are considering contraceptive implants so that potentially enormous long-term savings could be achieved. This study surveyed 98 women who had Norplant inserted and removed between January 1991 and December 1994. Data were collected from chart review, and when necessary, a questionnaire was used to extract information not found in the chart. The chi-squared statistic and t-test were used to compare demographic variables. All but one subject received comprehensive pre-implant counseling. The main reason given for electively removing the Norplant prematurely was irregular menstrual bleeding (60%). Pre-implant counseling did not influence the decision for removal. These results indicate the importance of clarifying patients' doubts regarding menstrual bleeding irregularities during follow-up visits rather than relying on the information patients received during preimplant counseling.

Entities:  

Keywords:  Americas; Blacks--women; Bleeding; Clinic Activities; Contraception; Contraception Termination; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Implants--side effects; Contraceptive Methods--side effects; Counseling; Cultural Background; Demographic Factors; Developed Countries; Diseases; Ethnic Groups; Family Planning; Levonorgestrel--side effects; Menstruation Disorders; North America; Northern America; Organization And Administration; Population; Population Characteristics; Program Activities; Programs; Research Methodology; Research Report; Sampling Studies; Signs And Symptoms; Studies; Surveys; Tennessee; United States; Whites--women

Mesh:

Substances:

Year:  1997        PMID: 9145628      PMCID: PMC2608206     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  5 in total

1.  Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.

Authors:  I Sivin; J Stern; S Diaz; M Pavéz; F Alvarez; V Brache; D R Mishell; M Lacarra; T McCarthy; P Holma
Journal:  Am J Obstet Gynecol       Date:  1992-04       Impact factor: 8.661

Review 2.  NORPLANT: levonorgestrel-releasing contraceptive implant.

Authors:  H B Croxatto
Journal:  Ann Med       Date:  1993-04       Impact factor: 4.709

3.  One-year experience with subdermal contraceptive implants in the United States.

Authors:  M L Frank; A N Poindexter; L M Cornin; C A Cox; L Bateman
Journal:  Contraception       Date:  1993-09       Impact factor: 3.375

4.  The significance of bleeding patterns in Norplant implant users.

Authors:  D Shoupe; D R Mishell; B L Bopp; M Fielding
Journal:  Obstet Gynecol       Date:  1991-02       Impact factor: 7.661

5.  Preliminary experience with Norplant in an inner city population.

Authors:  V E Cullins; P D Blumenthal; R E Remsburg; G R Huggins
Journal:  Contraception       Date:  1993-02       Impact factor: 3.375

  5 in total
  1 in total

1.  Norplant selection and satisfaction among low-income women.

Authors:  L L Clarke; K Schmitt; C A Bono; J Steele; M K Miller
Journal:  Am J Public Health       Date:  1998-08       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.